MEDICAL PROFESSIONAL HUB

Novavax is a biotechnology company committed to helping to address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.

Resources prepared for you to answer your questions

Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted)

Product summary for healthcare professionals, patient information, expiry date checker, FAQs, and more

Visit product authorization site

Global medical information site

Ask medical questions, report adverse events, and report product quality complaints

Visit medical information site

Publications

Source in-depth information about our research areas

Learn more about our research

Matrix-M adjuvant production process

Our vaccine uses saponins, from the Quillaja saponaria tree, to help generate a robust immune response.

Explore the Matrix-M production process

Producing a Novavax vaccine

Learn more about the 6 step process used to manufacture our vaccine.

Explore the process

Investigator-Initiated Studies (IIS)

The Novavax IIS program supports clinical and non-clinical research that addresses important unmet scientific or medical needs aligned with Novavax's areas of interest. Support for an approved IIS may include funding, Novavax product, or both.

Learn about the IIS program